Inhibitions of LRRFIP1/GCF2 by the transfection of short inhibitory RNA (siRNA) into a cervical carcinoma and colorectal cancer cell lines have been shown to reduce RhoA activation, migration, and cytoskeletal remodeling of the transfected cell lines [13,15]. This evidence concerns the gene RHOA and colorectal cancer.